【摘要】 目的 分析挫伤性前房积血治疗效果的影响因素。方法 回顾性研究2019年12月至2024年12月于唐山市眼科医院诊治的挫伤性前房积血381例(381眼)的临床资料，对影响治疗效果的因素进行分析。结果 单因素分析显示，前房积血程度(χ~2=26.53,P<0.001)、受伤至规范救治时间(χ~2=19.47,P=0.002)及是否合并血液系统疾病(P=0.028)与继发性青光眼/角膜血染症的发生显著相关。救治成功患者中，不同症状持续时间分组的眼压最高值差异有统计学意义(F=3.21,P=0.035)。381例挫伤性前房积血中发生继发性青光眼实施抗青光眼手术4例，占1.04%,角膜血染症实施角膜移植手术3例，占0.78%,治疗成功率98.16%(374/381)。出血量、受伤后距离规范救治时间、患者年龄及是否患有血液系统疾病均与继发性青光眼、角膜血染症发生率密切相关(P=0.028)。挫伤性前房积血救治成功患者，根据症状持续时间分时段分析眼压差异有统计学意义(P=0.035)。结论 前房积血量少、受伤后距离规范救治时间短及无血液系统疾病者，继发性青光眼及角膜血染症发生率低。更多还原

【Abstract】 Objective To analyze factors affecting treatment outcomes in patients with traumatic hyphema.Methods This retrospective study reviewed clinical data from 381 patients(381 eyes) with traumatic hyphema treated at Tangshan Ophthalmology Hospital between December 2019 and December 2024. Factors influencing treatment outcomes were analyzed.Results Univariate analysis showed that hyphema severity(χ~2=26.53,P<0.001), time from injury to receiving standardized treatment(χ~2=19.47,P=0.002), and presence of hematologic disease(P=0.028) were significantly associated with the occurrence of secondary glaucoma and corneal blood staining. Among patients with successful treatment, the maximum intraocular pressure(IOP) differed significantly across groups stratified by symptom duration(F=3.21,P=0.035). Of the 381 cases, four(1.04%) developed secondary glaucoma requiring antiglaucoma surgery and three(0.78%) developed corneal blood staining requiring corneal transplantation. The overall treatment success rate was 98.16%(374/381). Bleeding volume, delay to standardized treatment after injury, patient age, and presence of hematologic disease were all closely associated with the incidence of secondary glaucoma and corneal blood staining(P=0.028). The differences in intraocular pressure among patients who were successfully treated for traumatic hyphema were statistically significant when analyzed by time period based on symptom duration(P=0.035).Conclusion Patients with smaller hyphema volume, shorter delay to standardized treatment, and no underlying hematologic disease have a lower risk of developing secondary glaucoma and corneal blood staining.更多还原